Lipoprotein lipase (LPL) plays a crucial role in the hydrolysis of the triglyceride core of circulating chylomicrons and very low density lipoproteins (VLDL) and also has a major effect on the levels and lipid composition of high density lipoproteins (HDL). LPL deficiency is inherited as an autosomal recessive trait and most commonly presents with chylomicronaemia, abdominal pain, and eruptive xanthomata. We have previously described a mutation in exon 5 of the LPL gene which results in a substitution of glutamic acid for glycine at amino acid 188. We have now assessed 16 South African LPL deficient patients from nine separate kindreds for this mutation. Nine of these probands were homozygous for the mutation and were from four families, all of Indian descent. The ancestors of these probands have their origins in villages close to Bombay, India, which suggests a common ancestral mutation for the four Indian kindreds, particularly as the mutant allele in each family carried the identical restriction fragment length polymorphism (RFLP) haplotype. The presence of at least nine affected subjects in this small community around Cape Town is evidence for a higher than expected gene frequency for LPL deficiency in this population.
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Lipoprotein lipase (LPL) is a prominent enzyme in lipoprotein triglyceride metabolism and is located primarily on the luminal surface of the capillary endothelium where it is active against the triacylglyceride core of circulating chylomicrons and very low density lipoproteins. It plays a major role in the transport of lipids by releasing free fatty acids in the plasma compartment for uptake by tissues for catabolism or storage.
Genetic deficiencies of LPL are uncommon and generally occur at a carrier frequency of approximately 1:500.' LPL deficiency is inherited as an autosomal recessive trait and usually presents in childhood with abdominal pain, pancreatitis, hepatosplenomegaly, eruptive xanthoma, failure to thrive, and chylomic- Interestingly, all nine probands of Indian descent were found to carry this particular amino acid substitution while it was not detected in the seven other South African patients. These probands come from a community of less than 100 000 persons who live in and around Cape Town, which would suggest a higher than expected gene frequency for LPL deficiency in this population. We have been unable to confirm an ancestral relationship between the Indian patients, but it is noteworthy that the parents or grandparents in the four kindreds were born in closely adjacent villages on the outskirts of Bombay. It is thus likely that these kindreds share a common ancestral mutation.
Materials and methods

SUBJECTS
All the South African probands presented with findings characteristic of LPL deficiency, including fasting chylomicronaemia with plasma triglycerides in excess of 20 mmol/l. The absence of LPL activity in post-heparin plasma was shown by an in vitro assay incorporating triolein as substrate with an exogenous source of ApoCII.7 Clinical and laboratory findings on probands in three of the four Figure 3 The origins of the four kindreds from Cape Town with the Gly'88-lGlu mutation in the LPL gene can be traced to different villages close to Bombay. of these haplotypes, H 1 and H2 (table), accounted for 83% of the alleles examined with H2 being the most common, occurring on 34 of the 54 alleles.
To prove that the substitution of glutamic acid for glycine at residue 188 caused the defective LPL activity in these patients, in vitro site directed mutagenesis and COS-1 cell transfections were performed as previously described.'0 The mutagenic primer 5'-CAC-CAGAGAGTCCCCTG-3' was used to introduce the GGG(Gly) to GAG(Glu) transition.
Measurement of LPL activity in the medium from the cell cultures transfected with the mutant cDNA showed almost zero (1 1 nmol FFA/min/dish) lipolytic activity while the medium from cells transfected with the normal LPL cDNA showed a substantial level of activity at 124-7 nmol free fatty acid/ min/dish (total medium per dish= 6 This mutation has previously been described in affected persons of Dutch, English, and German descent. 6 The finding of this mutation in four separate Indian families from different villages but on the same haplotype (which is less common in this population) is further evidence for a common progenitor and might indicate that this mutation has occurred once and predates the spread of the Caucasian population to the Indian subcontinent.
The frequency of affected persons with LPL deficiency has been estimated at 1 in one million.' There are about 1 million South Africans of Indian origin who are descendants of persons arriving since 1860. The majority have their origins in Calcutta, Madras, and Bombay and settled in Natal where they worked on the sugar cane plantations. A small proportion (up to 5%) settled in the Cape, with most living in and around Cape Town. The isolation and rapid expansion of these communities has resulted in the increased prevalence of several genetic disorders among the Indian peoples. This has been well documented for thalassaemia, sickle cell anaemia, G6PD deficiency, and diabetes mellitus type 213 and might reflect a rapid expansion of the community from a small number of founders, some of whom carried mutations for these genetic diseases.
A significant proportion of the Indian community is, however, descended from persons who arrived relatively recently in South Africa, during the early part of this century. This period has not been sufficient time for a significant founder effect and it is possible that the increased frequency of some genetic diseases in this population reflects multiple sources of introduction of mutant genes.
The identification of nine LPL deficient probands in the Cape Town Indian community, with a total population of approximately 100 000, reflects a high frequency for LPL deficiency. Interestingly, most of the Indian kindreds settled around Cape Town have similar origins to those of the affected kindreds. This may indicate a higher than expected carrier frequency of LPL deficiency in members of the Indian community as a whole.
The clinical consequences of being a carrier for lipoprotein lipase deficiency are yet to be determined. However, recent evidence suggests that these subjects might have a variable hyperlipidaemia with an increased predisposition to atherosclerosis.'4 The ability to diagnose carrier status for LPL deficiency at the genomic level unequivocally will allow us to screen all members of these families and examine the phenotypic expression of LPL deficiency. Furthermore, screening for this mutation in persons of a similar origin who present with premature atherosclerosis and comparison with a control group will help to determine whether this mutation is associated with predisposition to increased atherogenesis in this community. This work was supported by the MRC-South Africa, the MRC-Canada, and the British Columbia Heart Foundation. Dr M R Hayden is an established investigator of the British Columbia Children's Hospital. We thank Dr Y Ha for constructive comments.
